Relaxing Legs Liquid
NDC Package 43689-0021-2
Package Information
Relaxing Legs (aconitum napellus, gnaphalium polycephalum, ledum palustre, magnesia phosphorica, rhus tox, viscum album) liquids is adults and children 12 years and above, dissolve 2 tablets under tongue 2 to 3 times daily or as directed by a physician.Children under 12 years, consult a physician. This formulation utilizes a liquid delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0021.
Identification & Billing
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 43689 - The Magni Company
- 43689-0021 - Relaxing Legs
- 43689-0021-2 - 1 BOTTLE in 1 CARTON / 125 LIQUID in 1 BOTTLE (43689-0021-1)
- 43689-0021 - Relaxing Legs
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43689-0021-2 identifies a specific commercial package of 1 bottle in 1 carton / 125 liquid in 1 bottle (43689-0021-1) of Relaxing Legs, a human over the counter drug labeled by The Magni Company. This liquid is formulated for oral use and contains aconitum napellus whole; magnesium phosphate, dibasic trihydrate; pseudognaphalium obtusifolium whole; rhododendron tomentosum leafy twig; toxicodendron pubescens leaf; viscum album fruiting top as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on May 09, 2016. The current certification is valid through December 31, 2026.
How is this The Magni Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689002102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.